Psychiatry and Neurology, Neurology · Houston, TX
NPI
1275613531
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6501 Fannin St, Nb 100
Houston, TX, 77030
Phone (713) 798-5975
Groups this clinician bills Medicare through
Medicare paid, 2024
$906K
70,656 services
Medicare patients, 2024
349
Average age 68
Drug cost, 2024
$5.6M
2,978 prescriptions
Company payments, 2025
$331
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George J Hutton was code J0897 (injection, denosumab, 1 mg), 3,060 times for 38 patients. In total George J Hutton billed 70,656 services in 60 codes, and Medicare paid $906K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,060 | 38 | $20.02 | $61K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 700 | 19 | $0.23 | $161 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 221 | 98 | $0.51 | $113 |
| 99214 Office E&M - Established | Office | 198 | 151 | $79.56 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 173 | 139 | $12.14 | $2,100 |
| 96401 Chemotherapy Administration | Office | 127 | 59 | $58.09 | $7,378 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 120 | 24 | $4.45 | $534 |
| 96413 Chemotherapy Administration | Office | 104 | 48 | $103.37 | $11K |
| 96365 Intravenous Infusion, Hydration | Office | 84 | 51 | $49.49 | $4,158 |
| 96375 Injection Administration | Office | 74 | 25 | $12.46 | $922 |
| 99215 Office E&M - Established | Office | 62 | 51 | $113.82 | $7,057 |
| 96415 Chemotherapy Administration | Office | 61 | 22 | $22.51 | $1,373 |
| 96366 Intravenous Infusion, Hydration | Office | 40 | 12 | $16.49 | $659 |
| 36415 Venipuncture Blood Collection | Office | 24 | 18 | $8.65 | $208 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 23 | 15 | $0.68 | $15.53 |
By year: 2022 $669K for 40,032 services; 2023 $1.1M for 61,890 services; 2024 $906K for 70,656 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 24 | 18 | $8.65 | $208 |
Medicare prescription drug claims, 2024
In 2024, the drug George J Hutton prescribed most often to Medicare patients was Baclofen, with 454 prescriptions and refills. In total George J Hutton wrote 2,978 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 454 | 837 | 101 | $13K |
| Gabapentin Generic | 379 | 727 | 100 | $11K |
| Dalfampridine Er Dalfampridine | 251 | 327 | 38 | $125K |
| Kesimpta Pen Ofatumumab | 197 | 197 | 22 | $1.9M |
| Duloxetine Hcl Generic | 154 | 277 | 29 | $3,217 |
| Tizanidine Hcl Generic | 103 | 180 | 24 | $1,228 |
| Modafinil Generic | 90 | 136 | 21 | $4,492 |
| Dimethyl Fumarate Generic | 69 | 79 | Under 11 | $26K |
| Copaxone Glatiramer Acetate | 64 | 65 | Under 11 | $372K |
| Escitalopram Oxalate Generic | 62 | 114 | Under 11 | $909 |
| Amitriptyline Hcl Generic | 54 | 98 | 14 | $855 |
| Armodafinil Generic | 47 | 49 | Under 11 | $2,526 |
| Solifenacin Succinate Generic | 46 | 80 | 12 | $2,120 |
| Teriflunomide Generic | 41 | 55 | Under 11 | $48K |
| Glatiramer Acetate Generic | 41 | 48 | Under 11 | $142K |
Brand drugs: 516 claims; generic drugs: 2,462 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George J Hutton $331 ($331 in general payments such as food, travel and fees) from 6 companies. The largest payer was TG Therapeutics, Inc. with $117.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.